News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
David Tougeron Shared Study on Prognostic Tool for Third-Line Chemotherapy in Unresectable Pancreatic Cancer
David Tougeron/oncologypro.esmo.org
Jun 25, 2025, 08:59

David Tougeron Shared Study on Prognostic Tool for Third-Line Chemotherapy in Unresectable Pancreatic Cancer

David Tougeron, Professor at Poitiers University Hospital, shared a post on LinkedIn:

“Very happy to share my last paper with Camille Evrard and many French digestive oncologists concerning the prognosis of third-line treatment in pancreatic cancer.
This tool determine survival in L3 and help treatment decision-making.
Try it!”

Title: Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based study

Journal: Oxford Academic

Authors: Camille Evrard, Antoine Pelras, Simon Rivet, Jean-Baptiste Bachet, Olivier Dubreuil, Anne-Laure Pointet, Julien Taieb, Widad Lahlou, Alix Portal, Céline Lepère, Thierry Lecomte, Romain Chautard, Nicolas Williet, Jean-Marc Phelip, Clélia Coutzac, Emilie Soularue, Lysiane Marthey, Raëf Abdallah, Anne Thirot Bidault, Pascal Artru, Jérome Desrame, Bertrand Le Roy, Marine Jary, Pascal Hammel, Isabelle Trouilloud, Nelson Lourenco, Vincent Hautefeuille, Laëtitia Dahan, Simon Pernot, Dominique Béchade, Astrid Pozet, Franck Bonnetain, Christophe Locher, Johann Dréanic, Romain Coriat, Bélinda Tchoundjeu, Yohann Foucher, David Tougeron

Read the full article.

David Tougeron

More posts featuring David Tougeron on OncoDaily. 

Alix Portal Anne Thirot Bidault Anne-Laure Pointet Antoine Pelras Astrid Pozet Bélinda Tchoundjeu Bertrand Le Roy Camille Evrard cancer Céline Lepère Christophe Locher Clelia Coutzac David Tougeron Dominique Béchade Emilie Soularue Franck Bonnetain Isabelle Trouilloud Jean-Baptiste Bachet Jean-Marc Phelip Jérome Desrame Johann Dréanic Julien Taieb Laetitia Dahan Lysiane Marthey Marine Jary Nelson Lourenco Nicolas Williet Olivier Dubreuil OncoDaily Oncology Pancreatic Cancer Pascal Artru Pascal Hammel Poitiers University Hospital Raëf Abdallah Romain Chautard Romain Coriat Simon Pernot Simon Rivet Thierry Lecomte Vincent Hautefeuille Widad Lahlou Yohann Foucher
Special Coverage
Insight
Jun 25, 2025, 08:59
David Tougeron Shared Study on Prognostic Tool for Third-Line Chemotherapy in Unresectable Pancreatic Cancer
Insight
Jun 25, 2025, 08:58
Zainul Aabideen Shared Details Upcoming "Pediatric Bone Marrow Transplant Course 2025"
Blog
Jun 25, 2025, 08:57
Digestive Cancers Europe Prepares for 10th DiCE Masterclass in Barcelona
Blog
Jun 25, 2025, 08:48
50 States in 50 Days with Ryan Trahan and Kia for Raising Awareness and Funds for Kids - St. Jude Children's Research Hospital
Blog
Jun 25, 2025, 08:46
Wee Joo Chng: We Concluded Another International Myeloma Study Group Summit - The Progress Has Been Tremendous
Dialogues
Jun 25, 2025, 08:45
Women Leaders in Oncology: Tara Frenkl on Hope, Elinzanetant, and HER2+ Lung Cancer Advances
Blog
Jun 25, 2025, 08:44
Luigi Formisano: Hot Topics at the 2025 GUiding INNOVATION Meeting
Blog
Jun 25, 2025, 08:43
Peter Pisters: I am Grateful to Our Nursing Community for Their Continued Commitment to Excellence for Our Patients
Blog
Jun 25, 2025, 08:43
Sakditad Saowapa: Grateful and Thrilled to Be Heading to ISTH Congress 2025
Career
Jun 25, 2025, 08:41
Nikhil Vojjala Received Young Investigator Program Trevel Scholarship for the SOHO 2025 Annual Meeting
Blog
Jun 25, 2025, 08:37
Bruno Paiva: The Sanofi Spain PostASCO and PostEHA 2025 Webinar is Here
Blog
Jun 25, 2025, 08:29
Vivek Subbiah Highlights STELLAR-303 Trial Results for Zanzalintinib Combo in mCRC